Skip to main content
Log in

What Is New in Low Gradient Aortic Stenosis: Surgery, TAVR, or Medical Therapy?

  • Structural Heart Disease (RJ Siegel and NC Wunderlich, Section Editors)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Background

A significant proportion of patients with aortic stenosis (AS) have discordance in severity by mean gradient/peak velocity and aortic valve area. Low gradient aortic stenosis (LG-AS) is defined when the aortic valve area is < 1 cm2 consistent with severe AS and mean aortic gradient is < 40 mmHg consistent with non-severe AS. LG-AS represents a diagnostic and therapeutic challenge.

Purpose of Review

To summarize the different categories, diagnosis, management, and prognosis of LG-AS. LG-AS is classified as classical (ejection fraction (EF) < 50%, indexed stroke volume (SVi) < 35 ml/m2), paradoxical (EF > 50%, SVi < 35 ml/m2), pseudo-severe (moderate AS with reduced EF), or normal flow low gradient AS.

Recent Findings

Recent findings emphasize the importance of low-dose dobutamine stress echocardiography and CT calcium score in the assessment of aortic valve. In addition, flow reserve (increase in SV > 50%) can be evaluated during dobutamine stress echocardiography and helps predict perioperative prognosis.

Summary

Patients with LG-AS have better survival with aortic valve replacement (AVR) compared to medical therapy, irrespective of presence or absence of flow reserve. Some recent studies suggest that transcatheter aortic valve replacement (TAVR) may be superior to surgical AVR for patients with a lack of contractile flow reserve or those with paradoxical LG-AS, but further investigation is needed to clarify optimal treatment. The role of TAVR in patients with moderate AS and reduced EF is also under investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24(13):1231–43.

    PubMed  Google Scholar 

  2. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22):e57–185.

    PubMed  Google Scholar 

  3. Minners J, Allgeier M, Gohlke-Baerwolf C, Kienzle RP, Neumann FJ, Jander N. Inconsistent grading of aortic valve stenosis by current guidelines: haemodynamic studies in patients with apparently normal left ventricular function. Heart. 2010;96(18):1463–8.

    PubMed  Google Scholar 

  4. Pibarot P, Dumesnil JG. Low-flow, low-gradient aortic stenosis with normal and depressed left ventricular ejection fraction. J Am Coll Cardiol. 2012;60(19):1845–53.

    PubMed  Google Scholar 

  5. Clavel MA, Magne J, Pibarot P. Low-gradient aortic stenosis. Eur Heart J. 2016;37(34):2645–57.

    PubMed  PubMed Central  Google Scholar 

  6. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–91.

    PubMed  Google Scholar 

  7. Herrmann HC, Pibarot P, Hueter I, Gertz ZM, Stewart WJ, Kapadia S, et al. Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: a Placement of Aortic Transcatheter Valves (PARTNER) trial analysis. Circulation. 2013;127(23):2316–26.

    PubMed  Google Scholar 

  8. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009;22(1):1–23. quiz 101-2.

    PubMed  Google Scholar 

  9. Baumgartner H, Hung J, Bermejo J, Chambers JB, Edvardsen T, Goldstein S, et al. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2017;30(4):372–92.

    PubMed  Google Scholar 

  10. Thaden JJ, Nkomo VT, Lee KJ, Oh JK. Doppler imaging in aortic stenosis: the importance of the nonapical imaging windows to determine severity in a contemporary cohort. J Am Soc Echocardiogr. 2015;28(7):780–5.

    PubMed  Google Scholar 

  11. Lancellotti P, Pellikka PA, Budts W, Chaudhry FA, Donal E, Dulgheru R, et al. The clinical use of stress echocardiography in non-Ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2017;30(2):101–38.

    PubMed  Google Scholar 

  12. Monin JL, Quere JP, Monchi M, Petit H, Baleynaud S, Chauvel C, et al. Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation. 2003;108(3):319–24.

    PubMed  Google Scholar 

  13. Blais C, Burwash IG, Mundigler G, Dumesnil JG, Loho N, Rader F, et al. Projected valve area at normal flow rate improves the assessment of stenosis severity in patients with low-flow, low-gradient aortic stenosis: the multicenter TOPAS (Truly or Pseudo-Severe Aortic Stenosis) study. Circulation. 2006;113(5):711–21.

    PubMed  Google Scholar 

  14. Clavel MA, Burwash IG, Mundigler G, Dumesnil JG, Baumgartner H, Bergler-Klein J, et al. Validation of conventional and simplified methods to calculate projected valve area at normal flow rate in patients with low flow, low gradient aortic stenosis: the multicenter TOPAS (True or Pseudo Severe Aortic Stenosis) study. J Am Soc Echocardiogr. 2010;23(4):380–6.

    PubMed  Google Scholar 

  15. Clavel MA, Ennezat PV, Marechaux S, Dumesnil JG, Capoulade R, Hachicha Z, et al. Stress echocardiography to assess stenosis severity and predict outcome in patients with paradoxical low-flow, low-gradient aortic stenosis and preserved LVEF. JACC Cardiovasc Imaging. 2013;6(2):175–83.

    PubMed  Google Scholar 

  16. Cueff C, Serfaty JM, Cimadevilla C, Laissy JP, Himbert D, Tubach F, et al. Measurement of aortic valve calcification using multislice computed tomography: correlation with haemodynamic severity of aortic stenosis and clinical implication for patients with low ejection fraction. Heart. 2011;97(9):721–6.

    PubMed  Google Scholar 

  17. •• Pawade T, Clavel MA, Tribouilloy C, Dreyfus J, Mathieu T, Tastet L, et al. Computed tomography aortic valve calcium scoring in patients with aortic stenosis. Circ Cardiovasc Imaging. 2018;11(3):e007146. Findings from this study suggest role of sex-specific CT aortic valve calcium score in identifying severe AS patients and predicting prognosis. The results from this study including subgroup of patients with LG-AS showed sex-specific CT aortic valve calcium score thresholds independently predicted aortic valve replacement and death.

    PubMed  Google Scholar 

  18. Clavel MA, Pibarot P, Messika-Zeitoun D, Capoulade R, Malouf J, Aggarval S, et al. Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study. J Am Coll Cardiol. 2014;64(12):1202–13.

    PubMed  PubMed Central  Google Scholar 

  19. Fanari Z, Gunasekaran PC, Shaukat A, Hammami S, Dawn B, Wiley M, et al. Safety and utility of dobutamine and pressure wire use in the hemodynamic assessment of low-flow, low-gradient aortic stenosis with reduced left ventricular ejection fraction. Cardiovasc Revasc Med. 2018;19(4):438–43.

    PubMed  Google Scholar 

  20. Connolly HM, Oh JK, Schaff HV, Roger VL, Osborn SL, Hodge DO, et al. Severe aortic stenosis with low transvalvular gradient and severe left ventricular dysfunction:result of aortic valve replacement in 52 patients. Circulation. 2000;101(16):1940–6.

    CAS  PubMed  Google Scholar 

  21. Tribouilloy C, Levy F, Rusinaru D, Gueret P, Petit-Eisenmann H, Baleynaud S, et al. Outcome after aortic valve replacement for low-flow/low-gradient aortic stenosis without contractile reserve on dobutamine stress echocardiography. J Am Coll Cardiol. 2009;53(20):1865–73.

    PubMed  Google Scholar 

  22. Clavel MA, Fuchs C, Burwash IG, Mundigler G, Dumesnil JG, Baumgartner H, et al. Predictors of outcomes in low-flow, low-gradient aortic stenosis: results of the multicenter TOPAS Study. Circulation. 2008;118(14 Suppl):S234–42.

    PubMed  Google Scholar 

  23. Levy F, Laurent M, Monin JL, Maillet JM, Pasquet A, Le Tourneau T, et al. Aortic valve replacement for low-flow/low-gradient aortic stenosis operative risk stratification and long-term outcome: a European multicenter study. J Am Coll Cardiol. 2008;51(15):1466–72.

    PubMed  Google Scholar 

  24. Dahou A, Magne J, Clavel MA, Capoulade R, Bartko PE, Bergler-Klein J, et al. Tricuspid regurgitation is associated with increased risk of mortality in patients with low-flow low-gradient aortic stenosis and reduced ejection fraction: results of the multicenter TOPAS study (True or Pseudo-Severe Aortic Stenosis). JACC Cardiovasc Interv. 2015;8(4):588–96.

    PubMed  Google Scholar 

  25. Zilberszac R, Gleiss A, Schweitzer R, Bruno P, Andreas M, Stelzmuller M, et al. Prognostic value of right ventricular dysfunction and tricuspid regurgitation in patients with severe low-flow low-gradient aortic stenosis. Sci Rep. 2019;9(1):14580.

    PubMed  PubMed Central  Google Scholar 

  26. Rosa VEE, Ribeiro HB, Sampaio RO, Morais TC, Rosa MEE, Pires LJT, et al. Myocardial fibrosis in classical low-flow, low-gradient aortic stenosis. Circ Cardiovasc Imaging. 2019;12(5):e008353.

    PubMed  Google Scholar 

  27. Sato K, Seo Y, Ishizu T, Takeuchi M, Izumo M, Suzuki K, et al. Prognostic value of global longitudinal strain in paradoxical low-flow, low-gradient severe aortic stenosis with preserved ejection fraction. Circ J. 2014;78(11):2750–9.

    PubMed  Google Scholar 

  28. Parikh V, Kim C, Siegel RJ, Arsanjani R, Rader F. Natriuretic peptides for risk stratification of patients with valvular aortic stenosis. Circ Heart Fail. 2015;8(2):373–80.

    PubMed  Google Scholar 

  29. Vamvakidou A, Jin W, Danylenko O, Chahal N, Khattar R, Senior R. Low Transvalvular flow rate predicts mortality in patients with low-gradient aortic stenosis following aortic valve intervention. JACC Cardiovasc Imaging. 2019;12(9):1715–24.

    PubMed  Google Scholar 

  30. Saeed S, Senior R, Chahal NS, Lonnebakken MT, Chambers JB, Bahlmann E, et al. Lower transaortic flow rate is associated with increased mortality in aortic valve stenosis. JACC Cardiovasc Imaging. 2017;10(8):912–20.

    PubMed  Google Scholar 

  31. •• Ribeiro HB, Lerakis S, Gilard M, Cavalcante JL, Makkar R, Herrmann HC, et al. Transcatheter aortic valve replacement in patients with low-flow, low-gradient aortic stenosis: the TOPAS-TAVI Registry. J Am Coll Cardiol. 2018;71(12):1297–308. Findings from this multicenter prospective study showed that TAVR was associated with good periprocedural outcomes in patients with low flow low gradient aortic stenosis AS. However, nearly one-third of these patients died at 2-year follow-up due to associated comorbidities and residual paravalvular leaks. Ejection fraction improved following TAVR, but dobutamine stress echo did not predict clinical outcomes or LVEF changes over time.

    PubMed  Google Scholar 

  32. Annabi MS, Clavel MA, Pibarot P. Dobutamine stress echocardiography in low-flow, low-gradient aortic stenosis: flow reserve does not matter anymore. J Am Heart Assoc. 2019;8(6):e012212.

    PubMed  PubMed Central  Google Scholar 

  33. Maes F, Lerakis S, Barbosa Ribeiro H, Gilard M, Cavalcante JL, Makkar R, et al. Outcomes from Transcatheter aortic valve replacement in patients with low-flow, low-gradient aortic stenosis and left ventricular ejection fraction less than 30%: a substudy from the TOPAS-TAVI Registry. JAMA Cardiol. 2019;4(1):64–70.

    PubMed  Google Scholar 

  34. Lauten A, Figulla HR, Mollmann H, Holzhey D, Kotting J, Beckmann A, et al. TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY). EuroIntervention. 2014;10(7):850–9.

    PubMed  Google Scholar 

  35. Fischer-Rasokat U, Renker M, Liebetrau C, van Linden A, Arsalan M, Weferling M, et al. 1-year survival after TAVR of patients with low-flow, low-gradient and high-gradient aortic valve stenosis in matched study populations. JACC Cardiovasc Interv. 2019;12(8):752–63.

    PubMed  Google Scholar 

  36. Chetcuti SJ, Deeb GM, Popma JJ, Yakubov SJ, Grossman PM, Patel HJ, et al. Self-expanding transcatheter aortic valve replacement in patients with low-gradient aortic stenosis. JACC Cardiovasc Imaging. 2019;12(1):67–80.

    PubMed  Google Scholar 

  37. Magne J, Mohty D. Paradoxical low-flow, low-gradient severe aortic stenosis: a distinct disease entity. Heart. 2015;101(13):993–5.

    PubMed  Google Scholar 

  38. Pibarot P, Dumesnil JG. Paradoxical low-flow, low-gradient aortic stenosis: new evidence, more questions. Circulation. 2013;128(16):1729–32.

    PubMed  Google Scholar 

  39. Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation. 2007;115(22):2856–64.

    PubMed  Google Scholar 

  40. Eleid MF, Sorajja P, Michelena HI, Malouf JF, Scott CG, Pellikka PA. Flow-gradient patterns in severe aortic stenosis with preserved ejection fraction: clinical characteristics and predictors of survival. Circulation. 2013;128(16):1781–9.

    PubMed  PubMed Central  Google Scholar 

  41. Cramariuc D, Cioffi G, Rieck AE, Devereux RB, Staal EM, Ray S, et al. Low-flow aortic stenosis in asymptomatic patients: valvular-arterial impedance and systolic function from the SEAS Substudy. JACC Cardiovasc Imaging. 2009;2(4):390–9.

    PubMed  Google Scholar 

  42. Dumesnil JG, Pibarot P, Carabello B. Paradoxical low flow and/or low gradient severe aortic stenosis despite preserved left ventricular ejection fraction: implications for diagnosis and treatment. Eur Heart J. 2010;31(3):281–9.

    PubMed  Google Scholar 

  43. Clavel MA, Burwash IG, Pibarot P. Cardiac imaging for assessing low-gradient severe aortic stenosis. JACC Cardiovasc Imaging. 2017;10(2):185–202.

    PubMed  Google Scholar 

  44. Kamperidis V, van Rosendael PJ, Katsanos S, van der Kley F, Regeer M, Al Amri I, et al. Low gradient severe aortic stenosis with preserved ejection fraction: reclassification of severity by fusion of Doppler and computed tomographic data. Eur Heart J. 2015;36(31):2087–96.

    CAS  PubMed  Google Scholar 

  45. Clavel MA, Malouf J, Messika-Zeitoun D, Araoz PA, Michelena HI, Enriquez-Sarano M. Aortic valve area calculation in aortic stenosis by CT and Doppler echocardiography. JACC Cardiovasc Imaging. 2015;8(3):248–57.

    PubMed  Google Scholar 

  46. Delgado V, Clavel MA, Hahn RT, Gillam L, Bax J, Sengupta PP, et al. How do we reconcile echocardiography, computed tomography, and hybrid imaging in assessing discordant grading of aortic stenosis severity? JACC Cardiovasc Imaging. 2019;12(2):267–82.

    PubMed  Google Scholar 

  47. Eleid MF, Nishimura RA, Sorajja P, Borlaug BA. Systemic hypertension in low-gradient severe aortic stenosis with preserved ejection fraction. Circulation. 2013;128(12):1349–53.

    PubMed  Google Scholar 

  48. Mohty D, Boulogne C, Magne J, Pibarot P, Echahidi N, Cornu E, et al. Prevalence and long-term outcome of aortic prosthesis-patient mismatch in patients with paradoxical low-flow severe aortic stenosis. Circulation. 2014;130(11 Suppl 1):S25–31.

    PubMed  Google Scholar 

  49. Mehrotra P, Jansen K, Flynn AW, Tan TC, Elmariah S, Picard MH, et al. Differential left ventricular remodelling and longitudinal function distinguishes low flow from normal-flow preserved ejection fraction low-gradient severe aortic stenosis. Eur Heart J. 2013;34(25):1906–14.

    CAS  PubMed  PubMed Central  Google Scholar 

  50. Osman M, Ghaffar YA, Foster T, Osman K, Alqahtani F, Shah K, et al. Meta-analysis of outcomes of transcatheter aortic valve implantation among patients with low gradient severe aortic stenosis. Am J Cardiol. 2019;124(3):423–9.

    PubMed  Google Scholar 

  51. Abramowitz Y, Chakravarty T, Pibarot P, Maeno Y, Kawamori H, Anderson D, et al. Characteristics and outcome following transcatheter aortic valve replacement in patients with severe aortic stenosis with low flow. EuroIntervention. 2017;13(12):e1428–e35.

    PubMed  Google Scholar 

  52. Biner S, Birati EY, Topilsky Y, Steinvil A, Ben Assa E, Sadeh B, et al. Outcome of transcatheter aortic valve implantation in patients with low-gradient severe aortic stenosis and preserved left ventricular ejection fraction. Am J Cardiol. 2014;113(2):348–54.

    PubMed  Google Scholar 

  53. Eleid MF, Sorajja P, Michelena HI, Malouf JF, Scott CG, Pellikka PA. Survival by stroke volume index in patients with low-gradient normal EF severe aortic stenosis. Heart. 2015;101(1):23–9.

    PubMed  Google Scholar 

  54. Garnier F, Eicher JC, Jazayeri S, Bertaux G, Bouchot O, Aho LS, et al. Usefulness and limitations of contractile reserve evaluation in patients with low-flow, low-gradient aortic stenosis eligible for cardiac resynchronization therapy. Eur J Heart Fail. 2014;16(6):648–54.

    PubMed  Google Scholar 

  55. Spitzer E, Ren B, Kroon H, van Gils L, Manintveld O, Daemen J, et al. Moderate aortic stenosis and reduced left ventricular ejection fraction: current evidence and challenges ahead. Front Cardiovasc Med. 2018;5:111.

    PubMed  PubMed Central  Google Scholar 

  56. Huded CP, Desai MY. Moderate aortic valve stenosis in patients with left ventricular systolic dysfunction-insights on prognosis and the potential role of early aortic valve replacement. J Thorac Dis. 2017;9(10):3590–3.

    PubMed  PubMed Central  Google Scholar 

  57. Delesalle G, Bohbot Y, Rusinaru D, Delpierre Q, Marechaux S, Tribouilloy C. Characteristics and prognosis of patients with moderate aortic stenosis and preserved left ventricular ejection fraction. J Am Heart Assoc. 2019;8(6):e011036.

    PubMed  PubMed Central  Google Scholar 

  58. Chadha G, Bohbot Y, Rusinaru D, Marechaux S, Tribouilloy C. Outcome of normal-flow low-gradient severe aortic stenosis with preserved left ventricular ejection fraction: a propensity-matched study. J Am Heart Assoc. 2019;8(19):e012301.

    PubMed  PubMed Central  Google Scholar 

  59. Gotzmann M, Lindstaedt M, Bojara W, Ewers A, Mugge A. Clinical outcome of transcatheter aortic valve implantation in patients with low-flow, low gradient aortic stenosis. Catheter Cardiovasc Interv. 2012;79(5):693–701.

    PubMed  Google Scholar 

  60. Le Ven F, Freeman M, Webb J, Clavel MA, Wheeler M, Dumont E, et al. Impact of low flow on the outcome of high-risk patients undergoing transcatheter aortic valve replacement. J Am Coll Cardiol. 2013;62(9):782–8.

    PubMed  Google Scholar 

  61. Amabile N, Agostini H, Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, et al. Impact of low preprocedural transvalvular gradient on cardiovascular mortality following TAVI: an analysis from the FRANCE 2 registry. EuroIntervention. 2014;10(7):842–9.

    PubMed  Google Scholar 

  62. Elhmidi Y, Piazza N, Krane M, Deutsch MA, Mazzitelli D, Lange R, et al. Clinical presentation and outcomes after transcatheter aortic valve implantation in patients with low flow/low gradient severe aortic stenosis. Catheter Cardiovasc Interv. 2014;84(2):283–90.

    PubMed  Google Scholar 

  63. Mohty D, Magne J, Deltreuil M, Aboyans V, Echahidi N, Cassat C, et al. Outcome and impact of surgery in paradoxical low-flow, low-gradient severe aortic stenosis and preserved left ventricular ejection fraction: a cardiac catheterization study. Circulation. 2013;128(11 Suppl 1):S235–42.

    PubMed  Google Scholar 

  64. Reinthaler M, Schwabe A, Landmesser U, Chung R, Aggarwal S, Delahunty N, et al. 'Paradoxical' low-flow, low-gradient severe aortic valve stenosis: an entity with limited improvement following transcatheter aortic valve implantation. J Heart Valve Dis. 2014;23(4):441–9.

    PubMed  Google Scholar 

  65. Baron SJ, Arnold SV, Herrmann HC, Holmes DR Jr, Szeto WY, Allen KB, et al. Impact of ejection fraction and aortic valve gradient on outcomes of transcatheter aortic valve replacement. J Am Coll Cardiol. 2016;67(20):2349–58.

    PubMed  PubMed Central  Google Scholar 

  66. Debry N, Sudre A, Amr G, Delhaye C, Schurtz G, Montaigne D, et al. Transcatheter aortic valve implantation for paradoxical low-flow low-gradient aortic stenosis patients. Catheter Cardiovasc Interv. 2016;87(4):797–804.

    PubMed  Google Scholar 

  67. Malkin CJ, Long WR, Baxter PD, Gale CP, Wendler O, Monaghan M, et al. Impact of left ventricular function and transaortic gradient on outcomes from transcatheter aortic valve implantation: data from the UK TAVI registry. EuroIntervention. 2016;11(10):1161–9.

    PubMed  Google Scholar 

  68. Schewel J, Schewel D, Frerker C, Wohlmuth P, Kuck KH, Schafer U. Invasive hemodynamic assessments during transcatheter aortic valve implantation: comparison of patient outcomes in higher vs. lower transvalvular gradients with respect to left ventricular ejection fraction. Clin Res Cardiol. 2016;105(1):59–71.

    PubMed  Google Scholar 

  69. Conrotto F, D'Ascenzo F, Stella P, Pavani M, Rossi ML, Brambilla N, et al. Transcatheter aortic valve implantation in low ejection fraction/low transvalvular gradient patients: the rule of 40. J Cardiovasc Med (Hagerstown). 2017;18(2):103–8.

    Google Scholar 

  70. Puls M, Korte KP, Bleckmann A, Huenlich M, Danner BC, Schoendube F, et al. Long-term outcomes after TAVI in patients with different types of aortic stenosis: the conundrum of low flow, low gradient and low ejection fraction. EuroIntervention. 2017;13(3):286–93.

    PubMed  Google Scholar 

  71. Kataoka A, Watanabe Y, Kozuma K, Nara Y, Nagura F, Kawashima H, et al. Prognostic impact of low-flow severe aortic stenosis in small-body patients undergoing TAVR: the OCEAN-TAVI Registry. JACC Cardiovasc Imaging. 2018;11(5):659–69.

    PubMed  Google Scholar 

  72. Mangner N, Stachel G, Woitek F, Haussig S, Schlotter F, Hollriegel R, et al. Predictors of mortality and symptomatic outcome of patients with low-flow severe aortic stenosis undergoing transcatheter aortic valve replacement. J Am Heart Assoc. 2018;7(8).

  73. Rodriguez-Gabella T, Nombela-Franco L, Auffret V, Asmarats L, Islas F, Maes F, et al. Transcatheter aortic valve implantation in patients with paradoxical low-flow. Low-Gradient Aortic Stenosis Am J Cardiol. 2018;122(4):625–32.

    PubMed  Google Scholar 

  74. Shah B, McDonald D, Paone D, Redel-Traub G, Jangda U, Guo Y, et al. Outcomes after transcatheter aortic valve replacement in patients with low versus high gradient severe aortic stenosis in the setting of preserved left ventricular ejection fraction. J Interv Cardiol. 2018;31(6):849–60.

    PubMed  Google Scholar 

  75. • Sato K, Sankaramangalam K, Kandregula K, Bullen JA, Kapadia SR, Krishnaswamy A, et al. Contemporary outcomes in low-gradient aortic stenosis patients who underwent dobutamine stress echocardiography. J Am Heart Assoc. 2019;8(6):e011168. Findings from this study suggest that in low-gradient AS with reduced ejection fraction, flow reserve or AS severity stratification by dobutamine stress echocardiography was not associated with survival.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sunil V. Mankad.

Ethics declarations

Conflict of Interest

Vidhu Anand, Sunil V. Mankad, and Mackram Eleid declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Structural Heart Disease

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anand, V., Mankad, S.V. & Eleid, M. What Is New in Low Gradient Aortic Stenosis: Surgery, TAVR, or Medical Therapy?. Curr Cardiol Rep 22, 78 (2020). https://doi.org/10.1007/s11886-020-01341-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11886-020-01341-x

Keywords

Navigation